MOLECULAR GENETICS AND METABOLISM

Scope & Guideline

Transforming Knowledge in Biochemistry and Genetics

Introduction

Welcome to your portal for understanding MOLECULAR GENETICS AND METABOLISM, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN1096-7192
PublisherACADEMIC PRESS INC ELSEVIER SCIENCE
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 1998 to 2024
AbbreviationMOL GENET METAB / Mol. Genet. Metab.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address525 B ST, STE 1900, SAN DIEGO, CA 92101-4495

Aims and Scopes

The journal "Molecular Genetics and Metabolism" primarily focuses on advancing the understanding of genetic and metabolic disorders through innovative research methodologies. It serves as a platform for disseminating findings related to the molecular and biochemical bases of inherited metabolic diseases, genetic variations, and treatment approaches.
  1. Genetic and Molecular Basis of Inherited Disorders:
    Research exploring the genetic mutations and molecular mechanisms underlying various inherited metabolic disorders, providing insights into their pathophysiology.
  2. Clinical Applications and Treatment Strategies:
    Studies that evaluate the efficacy of current treatments, including enzyme replacement therapies and novel pharmacological approaches, aimed at improving patient outcomes.
  3. Biochemical and Metabolic Profiling:
    Investigations into the metabolic profiles associated with specific genetic disorders to identify biomarkers for diagnosis and treatment monitoring.
  4. Patient-Centric Research:
    Research that emphasizes patient experiences, quality of life, and caregiver perspectives, contributing to a holistic understanding of the impact of metabolic diseases.
  5. Innovative Therapeutic Approaches:
    Development and evaluation of innovative therapies, including gene therapy, substrate reduction therapy, and pharmacological chaperones, to address metabolic disorders.
Recent publications indicate a trend towards more innovative and patient-focused research themes within the field of molecular genetics and metabolism. These emerging areas are vital for advancing understanding and treatment of genetic disorders.
  1. Gene Therapy and Genome Editing:
    An increasing number of studies focus on gene therapy techniques, including CRISPR and AAV-mediated gene delivery, highlighting their potential in treating metabolic disorders.
  2. Patient-Reported Outcomes and Quality of Life:
    Research emphasizing the importance of patient-reported outcomes and the psychosocial impact of metabolic diseases is gaining prominence, reflecting a shift towards patient-centered care.
  3. Multi-Omics Approaches:
    There is a growing trend towards integrating genomics, proteomics, and metabolomics to provide a more comprehensive understanding of metabolic disorders and their treatment.
  4. Telemedicine and Remote Monitoring:
    The COVID-19 pandemic has accelerated research into telemedicine and remote monitoring strategies, showcasing their effectiveness in managing patient care during public health crises.
  5. Personalized Medicine:
    Emerging themes in personalized medicine highlight the need for tailored treatment approaches based on individual genetic profiles, enhancing therapeutic efficacy.

Declining or Waning

While the journal remains focused on genetic and metabolic research, certain themes have shown a decline in prominence over recent years, reflecting shifts in research priorities and advancements in technology.
  1. Traditional Diagnostic Methods:
    There has been a noticeable decrease in publications focused on conventional diagnostic methods, as newer genomic and metabolomic techniques gain traction.
  2. General Population Studies:
    Research involving broad population studies without a specific focus on genetic or metabolic disorders has diminished, as more targeted studies are preferred.
  3. Basic Biochemistry without Clinical Relevance:
    Papers that explore basic biochemical pathways without direct clinical applications or implications for patient care are becoming less frequent.
  4. Animal Models with Limited Translational Relevance:
    Research utilizing animal models that do not effectively translate to human conditions or lack clear therapeutic implications is less commonly published.

Similar Journals

Annals of Pediatric Endocrinology & Metabolism

Catalyzing discoveries in diabetes and metabolic disorders.
Publisher: KOREAN SOC PEDIATRIC ENDOCRINOLOGYISSN: 2287-1012Frequency: 4 issues/year

Annals of Pediatric Endocrinology & Metabolism, published by the Korean Society of Pediatric Endocrinology, is a vital resource for researchers, healthcare professionals, and students in the fields of endocrinology, diabetes, and pediatric health. With its commitment to open access since 2012, the journal facilitates the dissemination of groundbreaking research on pediatric endocrine disorders and metabolic diseases, ensuring that vital knowledge is accessible to a global audience. The journal maintains a reputable standing with a 2023 Scopus rank of #92 in Pediatrics and a Q3 quartile in Endocrinology, highlighting its impact on the field. Originating from South Korea, the journal fosters a collaborative network of researchers and advocates best practices in pediatric care through interdisciplinary studies. The Annals not only enhances scientific understanding but also emphasizes practical applications aimed at improving child health outcomes, making it an essential publication for academics and practitioners alike.

INTERNATIONAL JOURNAL OF HUMAN GENETICS

Bridging Gaps in Human Genetic Understanding
Publisher: KAMLA-RAJ ENTERPRISESISSN: 0972-3757Frequency: 4 issues/year

INTERNATIONAL JOURNAL OF HUMAN GENETICS is a distinguished publication dedicated to advancing knowledge in the fields of genetics and molecular biology. Published by KAMLA-RAJ ENTERPRISES, this journal explores critical developments and research findings from 2008 to 2016, though its coverage in Scopus has since been discontinued. With an ISSN of 0972-3757 and an E-ISSN of 2456-6330, the journal aimed to foster scholarly dialogue and serve as a resource for researchers, professionals, and students engaged in human genetics. While the journal holds a modest ranking in categories such as Biochemistry and Genetics, it remains a vital source for exploring niche topics within the realm of human genetics. Researchers interested in genetic screening, gene therapy, and clinical genetics will find valuable insights herein. Despite its pause in indexing, the journal continues to contribute to the academic discourse by disseminating critical research that bridges gaps in understanding human genetics.

Molecular Genetics & Genomic Medicine

Transforming discoveries into clinical applications.
Publisher: WILEYISSN: 2324-9269Frequency: 12 issues/year

Molecular Genetics & Genomic Medicine, published by WILEY, is an esteemed and open-access journal that has been a prominent source of knowledge in the fields of genetics and molecular biology since its establishment in 2013. With an ISSN of 2324-9269, it aims to provide a platform for the dissemination of novel findings and innovative research that pushes the boundaries of genomics and its clinical applications. The journal holds a Q3 categorization in Genetics, Clinical Genetics, and Molecular Biology, reflecting its growing influence in these disciplines, as evidenced by its Scopus rankings. Researchers, professionals, and students alike will find valuable insights and advancements in genomic medicine, making this journal an essential resource for those dedicated to the understanding and application of genetic and molecular research in healthcare. Located at 111 River St, Hoboken, NJ, Molecular Genetics & Genomic Medicine continues to foster a global dialogue within the scientific community, ensuring accessible knowledge for all.

Cold Spring Harbor Perspectives in Medicine

Elevating Medical Research Through Expert Perspectives
Publisher: COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPTISSN: 2157-1422Frequency: 12 issues/year

Cold Spring Harbor Perspectives in Medicine is a premier academic journal published by the esteemed COLD SPRING HARBOR LAB PRESS that has become a crucial resource in the fields of Biochemistry, Genetics, and Medicine. With an impressive impact factor and consistently ranked in the Q1 quartile for both biochemistry and general medicine—as evidenced by its Scopus rankings of #21 and #26 respectively—this journal serves as an essential platform for disseminating high-quality research and comprehensive reviews from leading experts. Covering a convergence of knowledge spanning from 2011 through 2024, it plays a vital role in advancing the understanding of medical science. Researchers, professionals, and students alike benefit from Cold Spring Harbor Perspectives in Medicine, which offers a depth of insight into critical topics, emerging trends, and essential developments within the medical community. Join the conversation and contribute to the ongoing dialogue that drives innovation and excellence in medical research.

METABOLIC BRAIN DISEASE

Pioneering research in metabolic brain disorders.
Publisher: SPRINGER/PLENUM PUBLISHERSISSN: 0885-7490Frequency: 6 issues/year

METABOLIC BRAIN DISEASE, published by SPRINGER/PLENUM PUBLISHERS, is a leading journal dedicated to advancing our understanding of the metabolic processes impacting brain health and disease. Established in 1986 and set to continue until 2024, this journal encompasses a wide range of interdisciplinary research that intersects the fields of Biochemistry, Cellular and Molecular Neuroscience, and Neurology, as evidenced by its notable quartile placements in Q2 and Q3 for 2023. With an ISSN of 0885-7490 and an E-ISSN of 1573-7365, it serves as a vital resource for researchers and practitioners aiming to deepen their insights into cerebral metabolic disorders and their implications. Although currently not an Open Access option, its rigorous peer-review process ensures that high-quality, impactful research reaches its audience. Showcasing a significant rank within the top percentile of its categories, METABOLIC BRAIN DISEASE is instrumental in shaping the future of neurological research and clinical applications.

Cell Communication and Signaling

Illuminating the Pathways of Cellular Dialogue
Publisher: BMCISSN: Frequency: 1 issue/year

Cell Communication and Signaling is a premier peer-reviewed journal published by BMC that has made significant contributions to the fields of biochemistry, cell biology, and molecular biology since its establishment in 2003. As an open access journal, it offers unrestricted access to high-quality research, fostering collaboration and innovation among scientists around the globe. The journal is distinguished by its Q1 ranking in all three relevant categories for 2023, underscoring its critical role in advancing the understanding of cellular communication mechanisms and signaling pathways. Positioned within the United Kingdom, Cell Communication and Signaling has been an invaluable resource for researchers, professionals, and students alike, ensuring that the latest findings are accessible to a diverse range of audiences. With an impressive Scopus ranking—placing it in the top percentiles within its subject areas—this journal continues to set the standard for excellence in the pursuit of understanding complex cellular interactions.

HORMONE AND METABOLIC RESEARCH

Pioneering Research for Health and Disease Insights
Publisher: GEORG THIEME VERLAG KGISSN: 0018-5043Frequency: 12 issues/year

HORMONE AND METABOLIC RESEARCH, published by GEORG THIEME VERLAG KG, stands as a reputable platform in the fields of biochemistry, endocrinology, and metabolism since its establishment in 1969. This peer-reviewed journal provides critical insights and advancements in the intricate relationships between hormones and metabolic processes, catering to researchers, healthcare professionals, and students alike. With an impressive convergence of knowledge spanning over five decades, it maintains a commendable Q3 ranking in multiple categories, including Biochemistry, Clinical Biochemistry, and Endocrinology, highlighting its contribution to cutting-edge scientific discourse. Although not an open-access journal, it offers a plethora of access options for readers and institutions, ensuring that vital research reaches those who need it most. Located in Stuttgart, Germany, the journal is positioned at the forefront of influential research in hormone and metabolic studies, emphasizing its importance for ongoing investigations into health and disease.

AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Transforming understanding in endocrinology and metabolism.
Publisher: AMER PHYSIOLOGICAL SOCISSN: 0193-1849Frequency: 12 issues/year

American Journal of Physiology-Endocrinology and Metabolism, published by the American Physiological Society, stands as a leading platform for disseminating high-quality research in the fields of endocrinology, diabetes, and metabolism, as well as general physiology. With an impressive impact factor placing it within the Q1 category across multiple relevant disciplines (Endocrinology, Diabetes and Metabolism; Physiology; and Medical Physiology), this journal reflects its authoritative position in the scientific community. Spanning from 1980 to 2024, the journal consistently publishes groundbreaking studies and significant findings that advance our understanding of hormonal regulation and metabolic processes. Although it does not currently offer open access, it provides valuable resources for researchers, professionals, and students alike, eager to stay at the forefront of advancements in physiological sciences. Addressed in Rockville, Maryland, its commitment to excellence and rigorous peer review ensures that every article contributes essential insights to the field.

Hormones-International Journal of Endocrinology and Metabolism

Bridging Research and Clinical Practice in Endocrinology
Publisher: SPRINGER INT PUBL AGISSN: 1109-3099Frequency: 4 issues/year

Hormones - International Journal of Endocrinology and Metabolism, published by Springer International Publishing AG, is a vital resource within the field of Endocrinology, Diabetes, and Metabolism. Since its inception in 2005, this journal has made significant contributions to the understanding of hormonal mechanisms and their implications across various medical disciplines. With a current impact factor that places it in the Q3 category for Endocrinology and the Q2 category for miscellaneous Medicine – as indicated by its Scopus rankings – it stands out as a reputable platform for cutting-edge research and clinical findings. Although it operates under a subscription model, the journal's comprehensive scope encompasses basic and applied scientific studies, making it essential reading for researchers, clinicians, and students alike. The journal is headquartered in Germany with a strong commitment to promoting scholarly communication and knowledge dissemination within its specialized fields through the year 2024 and beyond.

JOURNAL OF INHERITED METABOLIC DISEASE

Uncovering the Secrets of Metabolic Disorders
Publisher: WILEYISSN: 0141-8955Frequency: 6 issues/year

JOURNAL OF INHERITED METABOLIC DISEASE, published by Wiley, stands at the forefront of research within the fields of genetics and clinical genetics. With an impressive impact factor reflected in its prestigious Q1 category rankings in both Genetics and Clinical Genetics, this journal provides a vital platform for groundbreaking studies and discoveries in inherited metabolic disorders. Since its inception in 1978 and continuing through 2024, it has consistently featured high-quality peer-reviewed articles that advance understanding and treatment options in this critical area of medicine. Researchers and professionals interested in the genetic underpinnings of metabolic diseases will find the journal's contributions invaluable for both their practical applications and theoretical advancements. Although it does not currently offer open access options, subscribers and readers who access the journal will benefit from rich, impactful content and findings that could influence clinical practices and future research initiatives in the field.